Latest Breaking News On - Aslan pharmaceuticals nasdaq - Page 1 : comparemela.com

ASLAN Pharmaceuticals (ASLN) Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference

ASLAN Pharmaceuticals (ASLN) Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesFerda cevikbasBronchial airway constrictionAslan pharmaceuticals nasdaqAmerican thoracic society international conferenceChronic obstructive pulmonary diseaseThoracic society international conferenceEblasakimab significantly alleviatesDerived lung slicesTranslational science

ASLAN Pharmaceuticals (ASLN) Announces Positive Interim Results From Phase 2 Study of Eblasakimab

ASLAN Pharmaceuticals (ASLN) Announces Positive Interim Results From Phase 2 Study of Eblasakimab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Carl firthAslan pharmaceuticals nasdaqEczema area severity indexChief executive officer

ASLAN Pharmaceuticals (ASLN) Receives Nasdaq Non-compliance Notice

ASLAN Pharmaceuticals (ASLN) Receives Nasdaq Non-compliance Notice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCompany american depositaryAslan pharmaceuticals nasdaqCompany formLetter for the companyNasdaq stock marketNasdaq listing ruleNasdaq capital marketStockholder equityAmerican depositary shares

ASLAN Pharmaceuticals (ASLN) Presents New Data on Eblasakimab in Atopic Dermatitis and COPD Translational Models

ASLAN Pharmaceuticals (ASLN) Presents New Data on Eblasakimab in Atopic Dermatitis and COPD Translational Models
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCarl firthShawn kwatra johns hopkinsFerda cevikbasPrecedence researchWorld health organizationAslan pharmaceuticals nasdaqDr madan kwatra duke universityInternational society of investigative dermatology meetingDrug development summitDermatology drug development summitJohns hopkins medicineDuke universityChief executive officerTranslational scienceInternational society

ASLAN Pharmaceuticals (ASLN) Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis

ASLAN Pharmaceuticals (ASLN) Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrancesj storrsEricl simpsonAlex kaoukhovEuropean academy of dermatologyScience universityOregon healthAslan pharmaceuticals nasdaqVenereology congressEuropean academyMedical dermatologyLead investigatorEczema areaSeverity indexChief medical officerInvestigator global assessment